Lead researcher
Dr Ashleigh Poh
Institution
The Olivia Newton-John Cancer Research Institute
Tumour type:
Colon, Melanoma, Lung
Years funded
(Jul 2017-Jun 2018)
What is the project?
This project exploits expression of the protein Haematopoietic Cell Kinase (HCK) as a novel target to improve the anti-cancer effects of immunotherapy and chemotherapy. The findings from this study will provide important mechanistic insights and pre-cinical proof-of-concept data to support future clinical trials with anti-HCK drugs to reduce tumour growth in patients.
This project exploits expression of the protein Haematopoietic Cell Kinase (HCK) as a novel target to improve the anti-cancer effects of immunotherapy and chemotherapy. The findings from this study will provide important mechanistic insights and pre-clinical proof-of–concept data to support future clinical trials with anti-HCK drugs to reduce tumour growth in patients.
|
Funding Body
Cancer Council Postdoctoral Fellowship